☰

Nicolette (Nikki) J. Sullivan, Ph.D. - Publications

Affiliations: 
1998-2002 Psychology, Neuroscience Miami University (Ohio), Oxford, OH 
 2006-2007 Social Sciences University of Chicago, Chicago, IL 
 2010-2015 Computation and Neural Systems California Institute of Technology, Pasadena, CA 
 2015-2019 Psychology and Neuroscience Duke University, Durham, NC 
 2019- Management, Marketing London School of Economics, London, England, United Kingdom 
Area:
Neuroeconomics
Website:
http://people.duke.edu/~njs28/
Tree Info Grants Similar researchers PubMed Report error

31 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Corti D, Misasi J, Mulangu S, Stanley DA, Kanekiyo M, Wollen S, Ploquin A, Doria-Rose NA, Staupe RP, Bailey M, Shi W, Choe M, Marcus H, Thompson EA, Cagigi A, ... ... Sullivan NJ, et al. Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody. Science (New York, N.Y.). PMID 26917593 DOI: 10.1126/Science.Aad5224  0.556
2016 Misasi J, Gilman MS, Kanekiyo M, Gui M, Cagigi A, Mulangu S, Corti D, Ledgerwood JE, Lanzavecchia A, Cunningham J, Muyembe-Tamfun JJ, Baxa U, Graham BS, Xiang Y, Sullivan NJ, et al. Structural and molecular basis for Ebola virus neutralization by protective human antibodies. Science (New York, N.Y.). PMID 26917592 DOI: 10.1126/Science.Aad6117  0.403
2015 De Santis O, Audran R, Pothin E, Warpelin-Decrausaz L, Vallotton L, Wuerzner G, Cochet C, Estoppey D, Steiner-Monard V, Lonchampt S, Thierry AC, Mayor C, Bailer RT, Mbaya OT, Zhou Y, ... ... Sullivan NJ, et al. Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study. The Lancet. Infectious Diseases. PMID 26725450 DOI: 10.1016/S1473-3099(15)00486-7  0.493
2015 Ledgerwood JE, Sullivan NJ, Graham BS. Chimpanzee Adenovirus Vector Ebola Vaccine--Preliminary Report. The New England Journal of Medicine. 373: 776. PMID 26287857 DOI: 10.1056/NEJMc1505499  0.483
2015 Zhou Y, Sullivan NJ. Immunology and evolvement of the adenovirus prime, MVA boost Ebola virus vaccine. Current Opinion in Immunology. 35: 131-6. PMID 26247875 DOI: 10.1016/j.coi.2015.06.006  0.529
2015 Regules JA, Beigel JH, Paolino KM, Voell J, Castellano AR, Muñoz P, Moon JE, Ruck RC, Bennett JW, Twomey PS, Gutiérrez RL, Remich SA, Hack HR, Wisniewski ML, Josleyn MD, ... ... Sullivan NJ, et al. A Recombinant Vesicular Stomatitis Virus Ebola Vaccine - Preliminary Report. The New England Journal of Medicine. PMID 25830322 DOI: 10.1056/Nejmoa1414216  0.645
2015 Rampling T, Ewer K, Bowyer G, Wright D, Imoukhuede EB, Payne R, Hartnell F, Gibani M, Bliss C, Minhinnick A, Wilkie M, Venkatraman N, Poulton I, Lella N, Roberts R, ... ... Sullivan NJ, et al. A Monovalent Chimpanzee Adenovirus Ebola Vaccine - Preliminary Report. The New England Journal of Medicine. PMID 25629663 DOI: 10.1056/Nejmoa1411627  0.635
2015 Kibuuka H, Berkowitz NM, Millard M, Enama ME, Tindikahwa A, Sekiziyivu AB, Costner P, Sitar S, Glover D, Hu Z, Joshi G, Stanley D, Kunchai M, Eller LA, Bailer RT, ... ... Sullivan NJ, et al. Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial. Lancet (London, England). 385: 1545-54. PMID 25540891 DOI: 10.1016/S0140-6736(14)62385-0  0.493
2015 Sullivan N, Hutcherson C, Harris A, Rangel A. Dietary self-control is related to the speed with which attributes of healthfulness and tastiness are processed. Psychological Science. 26: 122-34. PMID 25515527 DOI: 10.1177/0956797614559543  0.384
2015 Sarwar UN, Costner P, Enama ME, Berkowitz N, Hu Z, Hendel CS, Sitar S, Plummer S, Mulangu S, Bailer RT, Koup RA, Mascola JR, Nabel GJ, Sullivan NJ, Graham BS, et al. Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trial. The Journal of Infectious Diseases. 211: 549-57. PMID 25225676 DOI: 10.1093/Infdis/Jiu511  0.432
2014 Ledgerwood JE, DeZure AD, Stanley DA, Novik L, Enama ME, Berkowitz NM, Hu Z, Joshi G, Ploquin A, Sitar S, Gordon IJ, Plummer SA, Holman LA, Hendel CS, Yamshchikov G, ... ... Sullivan NJ, et al. Chimpanzee Adenovirus Vector Ebola Vaccine - Preliminary Report. The New England Journal of Medicine. PMID 25426834 DOI: 10.1056/Nejmoa1410863  0.619
2014 Reed PE, Mulangu S, Cameron KN, Ondzie AU, Joly D, Bermejo M, Rouquet P, Fabozzi G, Bailey M, Shen Z, Keele BF, Hahn B, Karesh WB, Sullivan NJ. A new approach for monitoring ebolavirus in wild great apes. Plos Neglected Tropical Diseases. 8: e3143. PMID 25232832 DOI: 10.1371/Journal.Pntd.0003143  0.329
2014 Stanley DA, Honko AN, Asiedu C, Trefry JC, Lau-Kilby AW, Johnson JC, Hensley L, Ammendola V, Abbate A, Grazioli F, Foulds KE, Cheng C, Wang L, Donaldson MM, Colloca S, ... ... Sullivan NJ, et al. Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge. Nature Medicine. 20: 1126-9. PMID 25194571 DOI: 10.1038/Nm.3702  0.596
2014 Paris R, Kuschner RA, Binn L, Thomas SJ, Colloca S, Nicosia A, Cortese R, Bailer RT, Sullivan N, Koup RA. Adenovirus type 4 and 7 vaccination or adenovirus type 4 respiratory infection elicits minimal cross-reactive antibody responses to nonhuman adenovirus vaccine vectors. Clinical and Vaccine Immunology : Cvi. 21: 783-6. PMID 24623627 DOI: 10.1128/CVI.00011-14  0.444
2012 Fausther-Bovendo H, Mulangu S, Sullivan NJ. Ebolavirus vaccines for humans and apes. Current Opinion in Virology. 2: 324-9. PMID 22560007 DOI: 10.1016/j.coviro.2012.04.003  0.429
2012 Sullivan NJ, Fausther-Bovendo H, Nabel GJ. Ebola vaccine Vaccines: Sixth Edition. 1060-1067. DOI: 10.1016/B978-1-4557-0090-5.00049-5  0.472
2011 Sullivan NJ, Hensley L, Asiedu C, Geisbert TW, Stanley D, Johnson J, Honko A, Olinger G, Bailey M, Geisbert JB, Reimann KA, Bao S, Rao S, Roederer M, Jahrling PB, et al. CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates. Nature Medicine. 17: 1128-31. PMID 21857654 DOI: 10.1038/Nm.2447  0.505
2011 Geisbert TW, Bailey M, Hensley L, Asiedu C, Geisbert J, Stanley D, Honko A, Johnson J, Mulangu S, Pau MG, Custers J, Vellinga J, Hendriks J, Jahrling P, Roederer M, ... ... Sullivan NJ, et al. Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge. Journal of Virology. 85: 4222-33. PMID 21325402 DOI: 10.1128/Jvi.02407-10  0.419
2010 Ledgerwood JE, Costner P, Desai N, Holman L, Enama ME, Yamshchikov G, Mulangu S, Hu Z, Andrews CA, Sheets RA, Koup RA, Roederer M, Bailer R, Mascola JR, Pau MG, ... Sullivan NJ, et al. A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults. Vaccine. 29: 304-13. PMID 21034824 DOI: 10.1016/J.Vaccine.2010.10.037  0.599
2010 Geisbert TW, Bailey M, Geisbert JB, Asiedu C, Roederer M, Grazia-Pau M, Custers J, Jahrling P, Goudsmit J, Koup R, Sullivan NJ. Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates. Journal of Virology. 84: 10386-94. PMID 20660192 DOI: 10.1128/Jvi.00594-10  0.477
2010 Hensley LE, Mulangu S, Asiedu C, Johnson J, Honko AN, Stanley D, Fabozzi G, Nichol ST, Ksiazek TG, Rollin PE, Wahl-Jensen V, Bailey M, Jahrling PB, Roederer M, Koup RA, ... Sullivan NJ, et al. Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species. Plos Pathogens. 6: e1000904. PMID 20502688 DOI: 10.1371/journal.ppat.1000904  0.501
2010 Shedlock DJ, Bailey MA, Popernack PM, Cunningham JM, Burton DR, Sullivan NJ. Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms. Virology. 401: 228-35. PMID 20304456 DOI: 10.1016/j.virol.2010.02.029  0.352
2009 Sullivan NJ, Martin JE, Graham BS, Nabel GJ. Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule. Nature Reviews. Microbiology. 7: 393-400. PMID 19369954 DOI: 10.1038/Nrmicro2129  0.529
2007 Oswald WB, Geisbert TW, Davis KJ, Geisbert JB, Sullivan NJ, Jahrling PB, Parren PW, Burton DR. Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys. Plos Pathogens. 3: e9. PMID 17238286 DOI: 10.1371/Journal.Ppat.0030009  0.356
2006 Martin JE, Sullivan NJ, Enama ME, Gordon IJ, Roederer M, Koup RA, Bailer RT, Chakrabarti BK, Bailey MA, Gomez PL, Andrews CA, Moodie Z, Gu L, Stein JA, Nabel GJ, et al. A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial. Clinical and Vaccine Immunology : Cvi. 13: 1267-77. PMID 16988008 DOI: 10.1128/Cvi.00162-06  0.563
2006 Sullivan NJ, Geisbert TW, Geisbert JB, Shedlock DJ, Xu L, Lamoreaux L, Custers JH, Popernack PM, Yang ZY, Pau MG, Roederer M, Koup RA, Goudsmit J, Jahrling PB, Nabel GJ. Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs. Plos Medicine. 3: e177. PMID 16683867 DOI: 10.1371/Journal.Pmed.0030177  0.488
2005 Jones SM, Feldmann H, Ströher U, Geisbert JB, Fernando L, Grolla A, Klenk HD, Sullivan NJ, Volchkov VE, Fritz EA, Daddario KM, Hensley LE, Jahrling PB, Geisbert TW. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nature Medicine. 11: 786-90. PMID 15937495 DOI: 10.1038/Nm1258  0.555
2003 Sullivan N, Yang ZY, Nabel GJ. Ebola virus pathogenesis: Implications for vaccines and therapies Journal of Virology. 77: 9733-9737. PMID 12941881 DOI: 10.1128/Jvi.77.18.9733-9737.2003  0.405
2003 Sullivan NJ, Geisbert TW, Geisbert JB, Xu L, Yang ZY, Roederer M, Koup RA, Jahrling PB, Nabel GJ. Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature. 424: 681-4. PMID 12904795 DOI: 10.1038/Nature01876  0.573
2000 Sullivan NJ, Sanchez A, Rollin PE, Yang ZY, Nabel GJ. Development of a preventive vaccine for Ebola virus infection in primates. Nature. 408: 605-9. PMID 11117750 DOI: 10.1038/35046108  0.523
2000 Nabel GJ, Sullivan NJ. Antibodies and resistance to natural HIV infection. The New England Journal of Medicine. 343: 1263-5. PMID 11071680 DOI: 10.1056/Nejm200010263431711  0.336
Show low-probability matches.